Mechanisims of asthma and allergic disease – 1085. Safety and tolerability of escalating doses of house dust mite peptide antigen desensitisation

Roderick Peter Hafner; Mark Larché; Paul Laidler; Pascal Hickey; Jacques Hébert

首页> 外文期刊>World Allergy Organization Journal >Mechanisims of asthma and allergic disease – 1085. Safety and tolerability of escalating doses of house dust mite peptide antigen desensitisation

【24h】

Mechanisims of asthma and allergic disease – 1085. Safety and tolerability of escalating doses of house dust mite peptide antigen desensitisation

机译：哮喘和过敏性疾病的发病机理–1085。室内尘螨肽抗原脱敏剂量递增的安全性和耐受性

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《World Allergy Organization Journal》 |2013年第s1期|1-1|共1页
作者
Roderick Peter Hafner; Mark Larché; Paul Laidler; Pascal Hickey; Jacques Hébert;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Mechanisims of asthma and allergic disease – 1085. Safety and tolerability of escalating doses of house dust mite peptide antigen desensitisation [J] . Roderick Peter Hafner, Mark Larché, Paul Laidler, World Allergy Organization Journal . 2013,第SUPPLEMENTa1期

机译：哮喘和过敏性疾病的发病机理–1085。室内尘螨肽抗原脱敏剂量递增的安全性和耐受性
2. Efficacy and tolerability of a house dust mite allergoid in allergic bronchial asthma: a randomized dose-ranging trial [J] . Marek Jutel, Michael Rudert, Fabian Kreimendahl, Immunotherapy . 2018,第13期

机译：过敏性支气管哮喘在过敏性支气管哮喘中的疗效和耐受性：随机剂量测量试验
3. Safety, tolerability, and impact on allergic inflammation of autologous E.coli autovaccine in the treatment of house dust mite asthma - a prospective open clinical trial [J] . Markus A Rose, Bianca Weigand, Ralf Schubert, BMC Complementary and Alternative Medicine . 2011,第1期

机译：自体大肠杆菌自身疫苗治疗屋尘螨哮喘的安全性，耐受性及其对过敏性炎症的影响-前瞻性开放临床试验
4. Sublingual immunotherapy in children with house dust mite induced allergic asthma [C] . Kumar Suman, Pey N., Sharma Nirankar, International Primary Care Respiratory Group . 2010

机译：含有房屋粉尘诱发过敏性哮喘的儿童的舌下免疫疗法
5. Mechanisims of asthma and allergic disease – 1085. Safety and tolerability of escalating doses of house dust mite peptide antigen desensitisation [O] . Roderick Peter Hafner, Mark Larché, Paul Laidler, 2013

机译：哮喘和过敏性疾病的发病机理–1085。室内尘螨肽抗原脱敏剂量递增的安全性和耐受性
6. Mechanisims of asthma and allergic disease – 1085. Safety and tolerability of escalating doses of house dust mite peptide antigen desensitisation [O] . 2013

机译：哮喘和过敏性疾病的发病机理–1085。室内尘螨肽抗原脱敏剂量递增的安全性和耐受性

Mechanisims of asthma and allergic disease – 1085. Safety and tolerability of escalating doses of house dust mite peptide antigen desensitisation

著录项

相似文献

相关主题

期刊订阅